open access

Vol 94, No 9 (2023)
Research paper
Published online: 2022-09-21
Get Citation

Does asymptomatic/uncomplicated SARS-CoV-2 infection during pregnancy increase the risk of spontaneous preterm birth?

Pınar Kumru1, Seyhan Hidiroglu2, Ebru Cogendez1, Habibe Ayvaci1, Betül Yilmazer1, Hümeyra Erol3, Oya Demirci1, Pınar Ay2
·
Pubmed: 36134763
·
Ginekol Pol 2023;94(9):704-713.
Affiliations
  1. Department of Obstetrics and Gynecology, University of Health Sciences, Zeynep Kamil Women and Children’s Disease Training and Research Hospital, Zeynep Kamil, Dr. Burhanettin Üstünel Sokağı, Üsküdar/İstanbul, Türkiye
  2. Department of Public Health, Marmara University Faculty of Medicine, Istanbul, Türkiye
  3. Division on Nursing, University of Health Sciences, Zeynep Kamil Women and Childrens Diesease Training and Research Hospital, Department of Obstetrics and Gynecology, İstanbul, Türkiye

open access

Vol 94, No 9 (2023)
ORIGINAL PAPERS Obstetrics
Published online: 2022-09-21

Abstract

Objectives: The aim of this study was to analyze the perinatal outcomes of asymptomatic/uncomplicated SARS-CoV-2 infection during pregnancy and the relationship between gestational age at the time of infection and spontaneous preterm birth (PTB). Material and methods: This was a retrospective cohort study. The study population included pregnant women who were 19–45 years old and who had been admitted to a Research and Training Hospital for singleton birth delivery. Women who had contracted SARS-CoV-2 during their pregnancy (n = 102) were compared to those who were not infected (n = 378) for the development of spontaneous PTB and other perinatal outcomes. The factors associated with spontaneous PTB were analyzed through univariate and multivariate methods. Results: Spontaneous PTB developed in 22.5% of the pregnant women with a history of SARS-CoV-2 infection and in 5.3% without a history of the infection (p < 0.001). The multivariate model determined that compared to the non-infected women, the OR of spontaneous PTB among those who had contracted the virus in the first, second, and the third trimesters were 9.13 (p < 0.001), 1.85 (p = 0.292) and 7.09 (p < 0.001), respectively. Pregnancy cholestasis (3.9% vs 0.5%; p = 0.020) and placental abruption (3.9% vs 0.5%; p = 0.040) were significantly higher in cases with a history of SARS-CoV-2 infection compared to the non-infected women. Conclusions: Asymptomatic or uncomplicated SARS-CoV-2 infection during pregnancy increases the risk of spontaneous PTB. This risk is higher particularly among pregnant women who develop the infection in the first and the third trimesters.

Abstract

Objectives: The aim of this study was to analyze the perinatal outcomes of asymptomatic/uncomplicated SARS-CoV-2 infection during pregnancy and the relationship between gestational age at the time of infection and spontaneous preterm birth (PTB). Material and methods: This was a retrospective cohort study. The study population included pregnant women who were 19–45 years old and who had been admitted to a Research and Training Hospital for singleton birth delivery. Women who had contracted SARS-CoV-2 during their pregnancy (n = 102) were compared to those who were not infected (n = 378) for the development of spontaneous PTB and other perinatal outcomes. The factors associated with spontaneous PTB were analyzed through univariate and multivariate methods. Results: Spontaneous PTB developed in 22.5% of the pregnant women with a history of SARS-CoV-2 infection and in 5.3% without a history of the infection (p < 0.001). The multivariate model determined that compared to the non-infected women, the OR of spontaneous PTB among those who had contracted the virus in the first, second, and the third trimesters were 9.13 (p < 0.001), 1.85 (p = 0.292) and 7.09 (p < 0.001), respectively. Pregnancy cholestasis (3.9% vs 0.5%; p = 0.020) and placental abruption (3.9% vs 0.5%; p = 0.040) were significantly higher in cases with a history of SARS-CoV-2 infection compared to the non-infected women. Conclusions: Asymptomatic or uncomplicated SARS-CoV-2 infection during pregnancy increases the risk of spontaneous PTB. This risk is higher particularly among pregnant women who develop the infection in the first and the third trimesters.

Get Citation

Keywords

SARS-CoV-2; COVID-19 pandemic; pregnancy; preterm birth; perinatal outcome

About this article
Title

Does asymptomatic/uncomplicated SARS-CoV-2 infection during pregnancy increase the risk of spontaneous preterm birth?

Journal

Ginekologia Polska

Issue

Vol 94, No 9 (2023)

Article type

Research paper

Pages

704-713

Published online

2022-09-21

Page views

494

Article views/downloads

418

DOI

10.5603/GP.a2022.0084

Pubmed

36134763

Bibliographic record

Ginekol Pol 2023;94(9):704-713.

Keywords

SARS-CoV-2
COVID-19 pandemic
pregnancy
preterm birth
perinatal outcome

Authors

Pınar Kumru
Seyhan Hidiroglu
Ebru Cogendez
Habibe Ayvaci
Betül Yilmazer
Hümeyra Erol
Oya Demirci
Pınar Ay

References (27)
  1. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---13-october-2021.
  2. Encinas Pardilla MB, Caño Aguilar A, Puig BM, et al. [Spanish registry of Covid-19 screening in asymptomatic pregnants] . Rev Esp Salud Publica. 2020; 94: e202009092.
  3. Ortiz Molina E, Hernandez Pailos R, Pola Guillen M, et al. COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis. Ginekol Pol. 2020; 91(12): 755–763.
  4. Khalil A, Hill R, Ladhani S, et al. Severe acute respiratory syndrome coronavirus 2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg. Am J Obstet Gynecol. 2020; 223(2): 296–297.
  5. Cavalcante MB, Cavalcante CT, Sarno M, et al. Maternal immune responses and obstetrical outcomes of pregnant women with COVID-19 and possible health risks of offspring. J Reprod Immunol. 2021; 143: 103250.
  6. WAPM (World Association of Perinatal Medicine) Working Group on COVID-19. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet Gynecol. 2021; 57(2): 232–241.
  7. Cruz Melguizo S, de la Cruz Conty ML, Carmona Payán P, et al. Pregnancy Outcomes and SARS-CoV-2 Infection: The Spanish Obstetric Emergency Group Study. Viruses. 2021; 13(5).
  8. Martinez-Perez O, Prats Rodriguez P, Muner Hernandez M, et al. Spanish Obstetric Emergency Group. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis. BMC Pregnancy Childbirth. 2021; 21(1): 273.
  9. Capobianco G, Saderi L, Aliberti S, et al. COVID-19 in pregnant women: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020; 252: 543–558.
  10. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/ (25.01.2021).
  11. Coustan DR, Carpenter MW, Carpenter MW, et al. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982; 144(7): 768–773.
  12. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122(5): 1122–1131.
  13. Hadlock FP, Harrist RB, Sharman RS, et al. Estimation of fetal weight with the use of head, body, and femur measurements--a prospective study. Am J Obstet Gynecol. 1985; 151(3): 333–337.
  14. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_43.pdf.
  15. Villar J, Ismail L, Victora C, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet. 2014; 384(9946): 857–868.
  16. Racicot K, Mor G, Silasi M, et al. Viral infections during pregnancy. Am J Reprod Immunol. 2015; 73(3): 199–213.
  17. Wastnedge EAN, Reynolds RM, van Boeckel SR, et al. Pregnancy and COVID-19. Physiol Rev. 2021; 101(1): 303–318.
  18. Smith V, Seo D, Warty R, et al. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review. PLoS One. 2020; 15(6): e0234187.
  19. Huntley BJF, Huntley ES, Di Mascio D, et al. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review. Obstet Gynecol. 2020; 136(2): 303–312.
  20. Knight M, Bunch K, Vousden N, et al. UK Obstetric Surveillance System SARS-CoV-2 Infection in Pregnancy Collaborative Group. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020; 369: m2107.
  21. Trocado V, Silvestre-Machado J, Azevedo L, et al. Pregnancy and COVID-19: a systematic review of maternal, obstetric and neonatal outcomes. J Matern Fetal Neonatal Med. 2022; 35(12): 2362–2374.
  22. Juan J, Gil MM, Rong Z, et al. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol. 2020; 56(1): 15–27.
  23. Hessami K, Homayoon N, Hashemi A, et al. COVID-19 and maternal, fetal and neonatal mortality: a systematic review. J Matern Fetal Neonatal Med. 2022; 35(15): 2936–2941.
  24. Elshafeey F, Magdi R, Hindi N, et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020; 150(1): 47–52.
  25. Smithgall MC, Liu-Jarin X, Hamele-Bena D, et al. Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization. Histopathology. 2020; 77(6): 994–999.
  26. Kuint J, Lerner-Geva L, Chodick G, et al. Israel Neonatal Network. Rehospitalization Through Childhood and Adolescence: Association with Neonatal Morbidities in Infants of Very Low Birth Weight. J Pediatr. 2017; 188: 135–141.e2.
  27. Martin JA, Hamilton BE, Osterman MJK, et al. Births: Final Data for 2018. Natl Vital Stat Rep. 2019; 68(13): 1–47.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl